ENTHEON BIOMEDICAL
Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products ("DMT Products") for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
ENTHEON BIOMEDICAL
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2010-04-06
Address:
Coquitlam, British Columbia, Canada
Country:
Canada
Website Url:
http://www.entheonbiomedical.com
Total Employee:
11+
Status:
Active
Contact:
604-562-3932
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-07-30 | Lobo Genetics | Lobo Genetics acquired by Entheon Biomedical | N/A |
| 2021-01-14 | HaluGen | HaluGen acquired by Entheon Biomedical | N/A |
Official Site Inspections
http://www.entheonbiomedical.com Semrush global rank: 5.69 M Semrush visits lastest month: 1.48 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Entheon Biomedical"
Entheon Biomedical
Jan 18, 2022 Intersecting established pharmacology with emerging medical technology, Entheon is developing a data-driven and comprehensive addiction recovery solution that personalizes …See details»
Entheon Biomedical - Crunchbase Company Profile & Funding
Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic …See details»
Entheon Biomedical Provides Update on Centre for Human Drug …
Vancouver, British Columbia--(Newsfile Corp. - February 2, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology …See details»
Entheon Biomedical | LinkedIn
There is a need for an alternative approach, that addresses the human cost of addiction for individuals, families and society at large. We are developing a DMT-assisted therapeutic …See details»
Entheon Biomedical Company Description - Stock Analysis
Company profile for Entheon Biomedical Corp. (ENTBF) with a description, list of executives, contact details and other key facts.See details»
Entheon Biomedical Corp. (ENBI.CN) - Yahoo Finance Canada
See the company profile for Entheon Biomedical Corp. (ENBI.CN) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Entheon Biomedica - Craft
Oct 29, 2024 Entheon Biomedical is a biotech company that focused on the development of psychedelic medicines for addiction disorders. It offers psychedelic treatments, drug …See details»
Entheon Biomedical - Overview, News & Similar companies
View Entheon Biomedical (www.entheonbiomedical.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»
Entheon Biomedical Corp - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Entheon Biomedical Corp of Coquitlam, BC. Get the latest business insights from Dun & Bradstreet.See details»
Entheon Biomedical - Psychedelic Invest
Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule. Entheon exists to invert the addiction …See details»
Entheon Biomedical Corp. | The Canadian Securities Exchange (CSE)
May 3, 2018 entheonbiomedical.com. Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders. Contacts. Email [email …See details»
Entheon Biomedical - Company Profile - Tracxn
Oct 11, 2024 Entheon Biomedical ranks 1st among 5 active competitors. 1 of its competitors is funded while 3 have exited. Overall, Entheon Biomedical and its competitors have raised over …See details»
Entheon Biomedical Announces Investment and Business …
Jan 4, 2021 Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology …See details»
Entheon Biomedical to be Included in First North American …
Jan 22, 2021 The Psychedelic ETF invests in North American publicly-listed companies focused on psychedelic medicines, providing diversified exposure to the psychedelics industry, and is …See details»
Entheon Biomedical Corp. (ENBI.CN) - Yahoo Finance Canada
Find the latest Entheon Biomedical Corp. (ENBI.CN) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Entheon Biomedical Announces the Approval of DMT Clinical Trial
Feb 3, 2022 Entheon is a biomedical company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide personalized treatment of addiction …See details»
Entheon Biomedical - Facebook
Entheon Biomedical. 423 likes · 1 talking about this. Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimSee details»
Entheon Biomedical Partners with Wavepaths on Upcoming …
Feb 16, 2022 Vancouver, British Columbia--(Newsfile Corp. - February 16, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), …See details»
Entheon Biomedical Provides Update on Clinical and Preclinical …
Nov 24, 2021 Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective N,N-dimethyltryptamine based …See details»